Young adult cancer survivors reluctant to get COVID vaccines
(Oxford University Press USA) A new paper in JNCI Cancer Spectrum indicates that many survivors of adolescent and young adult cancers hesitate to obtain COVID-19 vaccinations. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 29, 2021 Category: Cancer & Oncology Source Type: news
University of Surrey and partners highlight the importance of lived experience provided by prisoners
(University of Surrey) In a paper published by Research Involvement and Engagement, the University of Surrey and its partners highlight the importance and value of 'lived experience' that only people in prison can provide to shape meaningful research and policy decisions. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 29, 2021 Category: Cancer & Oncology Source Type: news
Study identifies biomarker that could help to diagnose pancreatic cancer
(Queen Mary University of London) Researchers from Queen Mary University of London have identified a protein that could be used to aid in the diagnosis of pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 29, 2021 Category: Cancer & Oncology Source Type: news
Microfilter device capable of detecting trace amounts of cancer cells in one mL of blood
(Kumamoto University) A microfilter device that can easily separate and capture trace amounts of cancer cells in blood has been developed by a Kumamoto University research group. The palm-sized device is expected to contribute to the development of new cancer diagnostic technologies based on cancer cells in the blood, such as early detection by blood test, postoperative management, and recurrence monitoring. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news
Response to COVID-19 vaccines varies widely in blood cancer patients
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Patients with a type of blood cancer called multiple myeloma had a widely variable response to COVID-19 vaccines--in some cases, no detectable response--pointing to the need for antibody testing and precautions for these patients after vaccination, according to a study published in Cancer Cell in June. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news
Blood stem cells make brain tumors more aggressive
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) Blood stem cells make brain tumors more aggressiveFor the first time, scientists from the German Cancer Consortium (DKTK) partner site in Essen/D ü sseldorf have discovered stem cells of the hematopoietic system in glioblastomas, the most aggressive form of brain tumor. These hematopoietic stem cells promote division of the cancer cells and at the same time suppress the immune response against the tumor. This surprising discovery might open up new possibilities for developing more effective immunotherapies against these malignant brain tumors. (Sourc...
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news
Fast IR imaging-based AI identifies tumor type in lung cancer
(Ruhr-University Bochum) The prognosis and effective therapies differ based on the type of lung cancer. While it previously took several days to precisely determine the underlying mutation, a research team at the Centre for Protein Diagnostics (PRODI) at Ruhr-Universit ä t Bochum (RUB) has been able to reliably perform this determination in just one step using a combination of quantum cascade laser-based infrared microscopy and artificial intelligence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news
New approach todrug design yields highly promising bladder cancer drug candidate
(Trinity College Dublin) A new approach to molecular drug design has yielded a highly promising bladder cancer drug, which induced rapid shedding of tumour cells and resulted in a significant reduction in tumour size when used in clinical trials. These potent effects were seen in patients with non-muscle invasive bladder cancer (NMIBC) and the treatment was shown to be safe, as no drug-related side effects were observed. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news
Moffitt receives $10.2 million grant to develop new lung cancer therapies
(H. Lee Moffitt Cancer Center& Research Institute) The National Cancer Institute has awarded the Lung Cancer Metabolism Working Group at Moffitt Cancer Center with a Research Program Project Grant (P01CA250984). The grant, which will provide more than $10.2 million over five years, will support team research with a focus on investigating lung cancer metabolism. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news
Study finds adverse effects of COVID-19 pandemic on cancer detection and surgical treatments
(American Cancer Society) A new study finds evidence for adverse effects of the COVID-19 pandemic on declines in cancer detection and surgical treatments. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news
Researchers discover protein complex that promotes cancer growth
(Geisinger Health System) A discovery by a team of researchers, led by a Geisinger professor, could yield a potential new treatment for breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news
Heart failure is associated with an increased risk of cancer
(European Society of Cardiology) A study in more than 200,000 individuals has found that patients with heart failure are more likely to develop cancer compared to their peers without heart failure. The research is presented today at Heart Failure 2021, an online scientific congress of the European Society of Cardiology (ESC), and published in ESC Heart Failure, a journal of the ESC. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news
Oncotarget: Novel markers of colorectal tumors exhibiting microsatellite instability
(Impact Journals LLC) By incorporating cell composition into their regression model, they identified 3,193 differentially expressed genes, of which 556 were deemed novel. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news
Oncotarget: Predicting clinical outcomes using cancer progression associated signatures
(Impact Journals LLC) The P142 panel of metrics successfully predicted cancer progression status in patients with some, but not all cancer types analyzed. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news
Oncotarget: Treatment outcomes in patients with advanced hepatocellular carcinoma
(Impact Journals LLC) In CTP class A patients, IGF/CTP score B was associated with shorter PFS and OS (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news
